Marex Group Limited research snapshot
MRX AI stock analysis as of the August 3, 2026 data cutoff reads Marex Group Limited as a fast-growing non-bank commodity clearing and brokerage platform trading at a reasonable valuation after a strong multi-quarter run. The stock closed at $64.92 on July 31, 2026, down 1.52% on the day, with a market capitalization near $4.67 billion, re-verified as $64.92 times 71.90 million shares outstanding. Q1 2026 revenue rose about 48% year over year to $692.3 million, net income reached $112.4 million, and EPS rose about 55% to $1.43, after a record FY2025 with revenue of $2.87 billion up about 22% and net income of $293.9 million up about 44%. The stock is up roughly 68% over the past 52 weeks and about 69% year to date, peaking at $71.18 in July 2026 before cooling. Recent catalysts include the completed Bermuda redomiciliation, a $500 million hybrid note offering, the announced Bright Point International acquisition for Asia Pacific clearing, the USDC margin collateral launch, and several price target raises from Jefferies, Piper Sandler, KBW, and Barclays. The main open questions are whether commodity volumes stay elevated, whether the Bright Point deal closes, and how quickly digital assets and new client wins keep driving earnings. This is informational research and not investment advice.
Current price
$64.92
Market cap
$4.67 billion
AI score
74 / 100
Rating
Quality growth franchise, fair valuation, consolidation after a strong run
Trend status
Uptrend intact but consolidating below the $71.18 all-time high after July gains
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Marex is a diversified non-bank commodity and financial brokerage, clearing, market making, and hedging platform with access to more than 60 exchanges. Revenue is transactional, volume-driven, and diversified across four segments, with a leading franchise in metals, energy, and agricultural products. | Medium-high |
| Moat | The moat comes from non-bank FCM status, the proprietary Neon trading platform, a global license network, clearing relationships with over 3,400 active clients, and scale across commodity markets. Narrow but defensible, and a key driver is banks retreating from commodities under capital rules. | Medium |
| Management | CEO Ian Lowitt has led since 2016 and the team has executed well since the IPO, delivering record 2025 results, Q1 2026 growth, a successful Bermuda redomiciliation, a $500 million hybrid note raise, and several acquisitions including Levmet and the announced Bright Point International deal. Key-person and integration risk remain watch items. | Medium |
| Financial trend | Q1 2026 revenue rose about 48% year over year to $692.3 million with net income of $112.4 million and EPS of $1.43, following record FY2025 revenue of $2.87 billion and net income of $293.9 million. TTM net income is about $333.8 million, with ROE near 29%. | Medium-high |
| Valuation | At the July 31, 2026 close, MRX traded near 14.9x trailing EPS, about 12x forward EPS on the $5.20 FY2026 adjusted estimate, near 1.4x sales, and near 7.1x trailing free cash flow, a discount to StoneX on trailing PE despite higher ROE and profit margins. | Medium |
| Technical trend | MRX is up about 68% over 52 weeks and about 69% year to date, peaked at $71.18 in July 2026, and closed at $64.92 on July 31. It sits above the 50-day moving average near $61.47 and well above the 200-day near $45.78, but below the 20-day near $65.09, with a neutral RSI near 52.6 signaling a consolidation phase. | Medium-high |
| Risk level | Key risks are dependence on commodity volume and volatility, high leverage with debt-to-equity near 9.7x that is typical for an FCM, integration and regulatory risk from acquisitions and the Bermuda redomiciliation, competition from StoneX and bank-owned FCMs, and the short public track record. Short interest is about 3.39 million shares or 4.71% of shares outstanding. | Medium-high |
| AI confidence | High for descriptive facts and math that matched across StockAnalysis.com, Barchart, and company press releases. Lower for forward return estimates because commodity volumes, deal timing, and digital asset adoption are uncertain. | High data confidence |
| Investment certainty | Low-medium certainty. The page gives a research framework and scenario ranges, not a buy or sell instruction, and the stock already reflects strong recent momentum. | Low-medium |
MRX AI stock forecast
The MRX AI stock forecast uses scenario math around the July 31, 2026 close of $64.92 and the FY2026 adjusted EPS estimate of $5.20. The three-scenario framework produced a bearish area near $47, a base area near $79, and a bullish area near $127 over three years, using adjusted EPS growth of 0%, 8%, and 15% and exit multiples of 9x, 12x, and 16x. These are scenarios, not price commitments.
$110 to $135
More likely if commodity volumes and volatility stay elevated, Marex keeps winning non-bank FCM market share as banks retreat, the Bright Point deal and further M&A add scale, digital assets and the USDC margin collateral capability drive new client growth, and the market re-rates the stock toward peer multiples near 15x forward earnings.
$70 to $88
More likely if Marex sustains mid-teens to high-teens adjusted EPS growth, commodity markets stay active but normalize, the Bright Point deal closes as expected, and the stock holds near an 11x to 13x forward multiple in line with recent analyst targets.
$40 to $52
More likely if commodity volume and volatility drop sharply, an acquisition disappoints or fails to close, leverage concerns intensify, competition from StoneX and bank FCMs pressures clearing share, or investors discount the multiple given the short public history.
MRX AI technical analysis
MRX AI technical analysis as of the August 3, 2026 data cutoff is bullish but consolidating. The stock closed at $64.92 on July 31, 2026, above the 50-day moving average near $61.47 and well above the 200-day near $45.78, but below the 20-day moving average near $65.09, with a neutral 14-day RSI near 52.6 and a low ADX near 11.8 signaling a sideways correction rather than a breakdown. The 52-week high of $71.18 remains the key upside level.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $64.92 | StockAnalysis.com real-time quote at the July 31, 2026 close; market cap math uses 71.90 million shares outstanding. |
| Near resistance | $65.09 to $67.01 | The 20-day moving average near $65.09 and the July 31 intraday high of $67.01 sit just overhead, capping the immediate bounce. |
| 52-week and all-time high | $71.18 | The July 2026 peak is the key breakout level. A close above it would signal trend continuation. |
| Near support | $61.47 | The 50-day moving average near $61.47, reported by both StockAnalysis.com and Barchart, is the first support zone. |
| Secondary support | $54.48 | The 100-day moving average near $54.48. A sustained break below it would weaken the medium-term setup. |
| 200-day moving average | $45.78 | The 200-day trend line near $45.78 is well below price, consistent with a strong longer-term uptrend. |
| 5-day and 20-day moving averages | $64.55 and $65.09 | Barchart reported the 5-day moving average near $64.55 and the 20-day near $65.09, both near the current price, showing near-term momentum is mixed. |
| Momentum | RSI near 52.6, ADX near 11.8 | The 14-day RSI near 52.6 is neutral, and the ADX near 11.8 from Barchart indicates a low-trending consolidation, not an overbought or oversold extreme. |
| Volume | About 720,000 to 730,000 average shares | StockAnalysis.com listed 20-day average volume near 721,834 shares and Barchart near 727,695 as of July 31, 2026, moderate for a mid-cap financial stock. |
| Volatility | 14-day historic volatility near 43% | Barchart reported 14-day historic volatility near 43.26%, so position sizing should account for larger swings around earnings and commodity moves. |
| Invalidation | Close below $61.47, then $54.48 | A decisive close below the 50-day moving average near $61.47 would weaken the near-term setup; a break below the 100-day near $54.48 would turn it bearish. |
MRX AI trading strategy
The MRX AI trading strategy is a rules-based research framework, not personalized advice. It combines filing-backed business evidence, technical confirmation, position sizing, and clear invalidation levels, and it should be refreshed with live market data before any decision.
Look for MRX to reclaim the 20-day moving average near $65.09 and build volume on a move toward the $67 to $71.18 resistance zone, with the 50-day near $61.47 and 200-day near $45.78 still rising.
A daily close back below the 50-day moving average near $61.47, or a failed attempt at the $71.18 high, should reduce confidence in the trend-following setup.
If MRX pulls back toward the $61.47 to $65 zone without a fundamental thesis break, compare the price reaction with commodity volume trends, Q2 2026 results due August 12, and news on the Bright Point deal before considering a position.
Use the $61.47 level as an invalidation point. Do not add to a position without fresh earnings, volume, or deal news confirming the thesis.
Track Marex quarterly earnings, commodity volume and volatility trends, FCM market share data, the Bright Point International and Levmet integration, digital asset and USDC margin adoption, Bermuda redomiciliation follow-through, management commentary, and peer valuations.
Lower the rating if revenue or earnings growth decelerates, an acquisition fails or dilutes returns, leverage becomes a funding issue, or competition intensifies in non-bank clearing.
Investment research summary
Marex provides commodity clearing, agency and execution, market making, and hedging and investment solutions to a global institutional client base, earning fees, spreads, and interest on client balances across more than 60 exchanges.
The narrow moat comes from non-bank FCM regulatory positioning, the proprietary Neon trading platform, global license coverage, clearing relationships with over 3,400 active clients, and scale in metals, energy, and agricultural products as banks retreat from commodities.
The thesis can fail if commodity volumes and volatility decline, an acquisition such as Bright Point International fails to close or integrates poorly, leverage becomes a funding problem, competition from StoneX and bank FCMs intensifies, or management overpays for growth.
CEO Ian Lowitt brings deep capital markets and management experience. The team has delivered record 2025 results, strong Q1 2026 growth, a completed Bermuda redomiciliation, a $500 million hybrid note raise, and a series of acquisitions. Key-person and integration risk are monitoring items.
Marex sits at the intersection of Basel III bank capital constraints, rising commodity hedging demand, energy transition markets, and maturing digital asset infrastructure including crypto derivatives clearing and stablecoin margin collateral. The non-bank FCM trend is a long-term tailwind.
At roughly 14.9x trailing earnings and about 12x forward EPS on the $5.20 FY2026 estimate, MRX trades at a discount to StoneX on trailing PE despite higher ROE and margins. The margin of safety depends on sustained commodity volumes, deal execution, and continued earnings growth.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| MRX price | $64.92 at the July 31, 2026 close, down 1.52% on the day | StockAnalysis.com real-time quote | August 3, 2026 |
| Market capitalization | $4.67 billion, computed as $64.92 x 71.90 million shares outstanding, verified via financial_rigor.py with 0.05% deviation | StockAnalysis.com quote and statistics | August 3, 2026 |
| Q1 2026 results | Revenue of $692.3 million up about 48% year over year, net income of $112.4 million, and EPS of $1.43 up about 55%, with operating income of $252.8 million | StockAnalysis.com quarterly financials and Marex Q1 2026 earnings materials | August 3, 2026 |
| FY2025 results | Revenue of $2.87 billion up 21.76% from $2.36 billion, and net income of $293.9 million up 43.58% | StockAnalysis.com overview and financial statements | August 3, 2026 |
| TTM revenue | About $3.27 billion on the StockAnalysis.com statistics page, up about 29% year over year; the financials page shows a net revenue basis of about $2.25 billion | StockAnalysis.com statistics and financials | August 3, 2026 |
| TTM net income and EPS | Net income of about $333.8 million and EPS of $4.37 over the trailing twelve months | StockAnalysis.com statistics | August 3, 2026 |
| Shares outstanding | 71.90 million shares outstanding | StockAnalysis.com statistics | August 3, 2026 |
| Valuation ratios | 14.86x trailing PE, 11.96x forward PE, 1.43x PS, 3.72x PB, 7.13x P/FCF, EV of $5.76 billion, EV/EBITDA of 6.63 | StockAnalysis.com statistics | August 3, 2026 |
| Forward estimates | FY2026 adjusted EPS estimate of $5.20 up 30.21% from $3.99, and FY2027 adjusted EPS of $5.82 up 12.04% | StockAnalysis.com forecast | July 27, 2026 |
| Balance sheet | Cash and equivalents of $12.02 billion, total debt of $13.12 billion, net cash of negative $1.09 billion, equity of $1.35 billion, and book value per share of $17.43, with debt-to-equity near 9.74 | StockAnalysis.com statistics | August 3, 2026 |
| Cash flow | Operating cash flow of about $667.5 million, capital expenditures of negative $13.1 million, and free cash flow of about $654.4 million over the trailing twelve months | StockAnalysis.com statistics and cash flow statement | August 3, 2026 |
| Profitability | ROE near 29.06%, ROA near 1.14%, operating margin near 14.3%, and profit margin near 10.6% | StockAnalysis.com statistics | August 3, 2026 |
| 52-week range and price change | 52-week range of $27.91 to $71.18, with the stock up about 68% over the past 52 weeks and about 69% year to date | StockAnalysis.com overview and statistics | August 3, 2026 |
| Analyst consensus | Buy with an average price target of $72.38 across 8 analysts, low of $36, median of $78, and high of $82 | StockAnalysis.com forecast and analyst ratings | July 27, 2026 |
| Analyst rating mix, July 2026 | 4 Strong Buy, 3 Buy, and 1 Hold out of 8 analysts | StockAnalysis.com forecast recommendation trends | July 27, 2026 |
| Recent analyst price target updates | Jefferies to $80 from $57 on July 20, Piper Sandler to $75 from $55 on July 15, KBW to $80 from $60 on July 9, Barclays to $76 from $60 on July 9, and Goldman Sachs to $62 on June 30 | StockAnalysis.com forecast and Yahoo Finance news | July 27, 2026 |
| Earnings date | Q2 2026 results scheduled for release before market open on August 12, 2026 | Marex Group Limited press release via GlobeNewswire | July 27, 2026 |
| Bermuda redomiciliation | The scheme to redomicile Marex to Bermuda became effective July 1, 2026, and the company now operates as Marex Group Limited | Marex Group press release via GlobeNewswire | July 1, 2026 |
| Bright Point International acquisition | Agreed on July 9, 2026 to acquire Bright Point International, a Singapore-based Asian-focused clearing business adding about $800 million in client balances and over 70 employees, with completion expected late 2026 or early 2027 subject to regulatory approval | Marex Group press release via GlobeNewswire | July 9, 2026 |
| USDC margin collateral | On July 16, 2026, Marex launched the ability for clients to post USDC as initial margin collateral in collaboration with Circle, Coinbase, and Prime Trading LLC, following a CFTC no-action letter on digital assets as collateral | Marex Group press release via GlobeNewswire | July 16, 2026 |
| $500 million hybrid notes | Closed a US$500 million hybrid note offering on June 9, 2026, which was oversubscribed, as part of funding the growth strategy | Marex Group press release via GlobeNewswire | June 9, 2026 |
| Levmet acquisition | Acquired Levmet on June 1, 2026, a Monaco-based liquidity provider in physical and derivatives markets across base metals, ferrous metals, energy, and power | Marex Group press release via GlobeNewswire | June 1, 2026 |
| Short interest | 3.39 million shares short, 4.71% of shares outstanding, 6.32% of float, with 3.43 days to cover | StockAnalysis.com statistics short selling | August 3, 2026 |
| Dividend | Annual dividend of $0.64 per share with a yield near 0.99% and a payout ratio near 14.65%, with the most recent ex-dividend date on May 18, 2026 | StockAnalysis.com dividend and statistics | August 3, 2026 |
| Technical snapshot | 5-day moving average near $64.55, 20-day near $65.09, 50-day near $61.47, 100-day near $54.48, 200-day near $45.78, 14-day RSI near 52.6, 14-day ADX near 11.8, 14-day historic volatility near 43.26% | Barchart and StockAnalysis.com technical snapshots | August 3, 2026 |
| StoneX comparison | StoneX (SNEX), the closest comparable, trades near 20.3x trailing EPS with a market cap near $9.10 billion as of July 31, 2026, after a 1.5:1 forward stock split on July 20, 2026 | StockAnalysis.com StoneX statistics | August 3, 2026 |
This MRX AI stock analysis is an informational tool for research and education only. It is not investment advice, a recommendation, or a guarantee of future performance. Forecast ranges are scenarios based on available data as of the stated cutoff and can be wrong.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
